Robert J. Bitterman
President & CEO at Phio Pharmaceuticals Corp.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Phio Pharmaceuticals Corp., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Phio Pharmaceuticals Corp. September 28, 202696.9%
-
Phio Pharmaceuticals Corp. September 11, 202591.6%
-
Phio Pharmaceuticals Corp. June 17, 202490.0%
-
Phio Pharmaceuticals Corp. July 20, 202387.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 9, 2026 | Phio Pharmaceuticals Corp. | Open-market purchase | +25,000 | $0.82 | $20,500 |
| Sep 28, 2026 | Phio Pharmaceuticals Corp. | Grant or award | +400,000 | — | — |
| Sep 22, 2026 | Phio Pharmaceuticals Corp. | Open-market purchase | +2,000 | $1.03 | $2,060 |
| Sep 11, 2026 | Phio Pharmaceuticals Corp. | Shares withheld for tax | −68,550 | $1.03 | $70,607 |
| Aug 18, 2026 | Phio Pharmaceuticals Corp. | Open-market purchase | +10,000 | $1.06 | $10,600 |
| Jun 26, 2026 | Phio Pharmaceuticals Corp. | Open-market purchase | +10,000 | $0.99 | $9,900 |
| Feb 5, 2026 | Phio Pharmaceuticals Corp. | Grant or award | +120,000 | — | — |
| Dec 31, 2025 | Phio Pharmaceuticals Corp. | Open-market purchase | +5,000 | $1.03 | $5,150 |
| Dec 23, 2025 | Phio Pharmaceuticals Corp. | Open-market purchase | +5,000 | $1.02 | $5,100 |
| Nov 21, 2025 | Phio Pharmaceuticals Corp. | Open-market purchase | +5,000 | $1.14 | $5,700 |
| Nov 18, 2025 | Phio Pharmaceuticals Corp. | Open-market purchase | +5,000 | $1.27 | $6,350 |
| Sep 11, 2025 | Phio Pharmaceuticals Corp. | Shares withheld for tax | −4,111 | $2.32 | $9,538 |
| Sep 11, 2025 | Phio Pharmaceuticals Corp. | Grant or award | +250,000 | — | — |
| Jun 10, 2025 | Phio Pharmaceuticals Corp. | Open-market purchase | +2,000 | $2.42 | $4,840 |
| Jun 9, 2025 | Phio Pharmaceuticals Corp. | Open-market purchase | +1,500 | $2.75 | $4,125 |
Questions about Robert J. Bitterman
What boards is Robert J. Bitterman on?
Robert J. Bitterman sits on the board of Phio Pharmaceuticals Corp.
What company is Robert J. Bitterman the CEO of?
Robert J. Bitterman is President & CEO of Phio Pharmaceuticals Corp.
How long has Robert J. Bitterman served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.